TrialAntimicrobial agents and chemotherapy2014

Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.

Shalini Yapa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.